Patient, care partner, and provider voice in treatment decision-making for non-small cell lung cancer

IF 2.9 2区医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Patient Education and Counseling Pub Date : 2025-04-04 DOI:10.1016/j.pec.2025.108776

Lisa Dwyer Orr , Julie Vanderpoel , Pratyusha Vadagam , Manali Indravadan Patel , Upal Basu Roy , Blanca Ledezma , Margaret Yung , Kathleen L. Deering , Victoria Kulbokas , Josh Feldman , Jhanelle E. Gray

{"title":"Patient, care partner, and provider voice in treatment decision-making for non-small cell lung cancer","authors":"Lisa Dwyer Orr , Julie Vanderpoel , Pratyusha Vadagam , Manali Indravadan Patel , Upal Basu Roy , Blanca Ledezma , Margaret Yung , Kathleen L. Deering , Victoria Kulbokas , Josh Feldman , Jhanelle E. Gray","doi":"10.1016/j.pec.2025.108776","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>Describe the treatment attributes that patients, care partners, and clinicians prioritize when making decisions about non-small cell lung cancer (NSCLC) as well as each group’s perspectives regarding shared decision-making (SDM).</div></div><div><h3>Materials and Methods</h3><div>Cross-sectional online surveys were conducted between March andMay 2023. Adult patients and care partners were recruited from Inspire, a closed online health community, and clinicians (oncologists, nurse practitioners, physician assistants) were recruited separately from M3 Global Research databases. Survey questions were informed by a literature review, interviews, and steering committee input.</div></div><div><h3>Results</h3><div>160 patients and 30 care partners (0.3 % of those invited and 15 % of those who responded to the email invitation), and 150 clinicians (5 % of those invited and 43 % of those who responded to the email invitation) completed the surveys. Across all groups, expected overall survival was the most important treatment attribute. Quality of life, ranked second by patients and care partners, was ranked fourth by clinicians. When asked about SDM, 11 % of patients with early-stage NSCLC and 12 % of those with advanced disease wanted their doctor to make treatment decisions after considering their opinion. However, 53 % of clinicians thought patients preferred that they make the final decision in later disease stages.</div></div><div><h3>Conclusion</h3><div>Patients with NSCLC, care partners, and clinicians generally agreed on the most important treatment attributes. However, aligning on SDM practices could help achieve more effective NSCLC management.</div></div><div><h3>Practice Implications</h3><div>Our study reinforces the relevance of SDM in NSCLC; however, some patients who wish for greater involvement in decisions may find their preferences overlooked.</div></div>","PeriodicalId":49714,"journal":{"name":"Patient Education and Counseling","volume":"136 ","pages":"Article 108776"},"PeriodicalIF":2.9000,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Patient Education and Counseling","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0738399125001430","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives

Describe the treatment attributes that patients, care partners, and clinicians prioritize when making decisions about non-small cell lung cancer (NSCLC) as well as each group’s perspectives regarding shared decision-making (SDM).

Materials and Methods

Cross-sectional online surveys were conducted between March andMay 2023. Adult patients and care partners were recruited from Inspire, a closed online health community, and clinicians (oncologists, nurse practitioners, physician assistants) were recruited separately from M3 Global Research databases. Survey questions were informed by a literature review, interviews, and steering committee input.

Results

160 patients and 30 care partners (0.3 % of those invited and 15 % of those who responded to the email invitation), and 150 clinicians (5 % of those invited and 43 % of those who responded to the email invitation) completed the surveys. Across all groups, expected overall survival was the most important treatment attribute. Quality of life, ranked second by patients and care partners, was ranked fourth by clinicians. When asked about SDM, 11 % of patients with early-stage NSCLC and 12 % of those with advanced disease wanted their doctor to make treatment decisions after considering their opinion. However, 53 % of clinicians thought patients preferred that they make the final decision in later disease stages.

Conclusion

Patients with NSCLC, care partners, and clinicians generally agreed on the most important treatment attributes. However, aligning on SDM practices could help achieve more effective NSCLC management.

Practice Implications

Our study reinforces the relevance of SDM in NSCLC; however, some patients who wish for greater involvement in decisions may find their preferences overlooked.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Patient Education and Counseling 医学-公共卫生、环境卫生与职业卫生

CiteScore

5.60

自引率

11.40%

发文量

384

审稿时长

46 days

期刊介绍： Patient Education and Counseling is an interdisciplinary, international journal for patient education and health promotion researchers, managers and clinicians. The journal seeks to explore and elucidate the educational, counseling and communication models in health care. Its aim is to provide a forum for fundamental as well as applied research, and to promote the study of organizational issues involved with the delivery of patient education, counseling, health promotion services and training models in improving communication between providers and patients.